首页> 外文期刊>European urology >Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence
【24h】

Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence

机译:在女性应激性尿失禁的外科手术中,对阴道粘连,耻骨后吊带和尿道中带的比较数据进行了更新的系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Burch colposuspension, pubovaginal sling, and midurethral retropubic tape (RT) and transobturator tape (TOT) have been the most popular surgical treatments for female stress urinary incontinence (SUI). Several randomized controlled trials (RCTs) have been published comparing the different techniques, with conflicting results. Objective: Our aim was to evaluate the efficacy, complication, and reoperation rates of midurethral tapes compared with other surgical treatments for female SUI. Evidence acquisition: A systematic review of the literature was performed using the Medline, Embase, Scopus, Web of Science databases, and Cochrane Database of Systematic Reviews. Evidence synthesis: Thirty-nine RCTs were identified. Patients receiving midurethral tapes had significantly higher overall (odds ratio [OR]: 0.61; confidence interval [CI]: 0.46-0.82; p = 0.00009) and objective (OR: 0.38; CI: 0.25-0.57; p < 0.0001) cure rates than those receiving Burch colposuspension, although they had a higher risk of bladder perforations (OR: 4.94; CI: 2.09-11.68; p = 0.00003). Patients undergoing midurethral tapes and pubovaginal slings had similar cure rates, although the latter were slightly more likely to experience storage lower urinary tract symptoms (LUTS) (OR: 0.31; CI: 0.10-0.94; p = 0.04) and had a higher reoperation rate (OR: 0.31; CI: 0.12-0.82; p = 0.02). Patients treated with RT had slightly higher objective cure rates (OR: 0.8;CI: 0.65-0.99; p = 0.04) than those treated with TOT; however, subjective cure rates were similar, and patients treated with TOT had a much lower risk of bladder and vaginal perforations (OR: 2.5; CI: 1.75-3.57; p < 0.00001), hematoma (OR: 2.62; CI: 1.35-5.08; p = 0.005), and storage LUTS (OR: 1.35; CI: 1.05-1.72; p = 0.02). Meta-analysis demonstrated similar outcomes for TVT-O (University of Lige, Lige, Wallonia, Belgium) and Monarc (AMS, Minnetonka, MN, USA). Conclusions: Patients treated with RT experienced slightly higher continence rates than those treated with Burch colposuspension, but they faced a much higher risk of intraoperative complications. RT and pubovaginal slings were similarly effective, although patients with pubovaginal slings were more likely to experience storage LUTS. The use of RT was followed by objective cure rates slightly higher than TOT, but subjective cure rates were similar. TOT had a lower risk of bladder and vaginal perforations and storage LUTS than RT. The strength of these findings is limited by the heterogeneity of the outcome measures and the short length of follow-up.
机译:背景:Burch阴道痉挛,耻骨前吊带,尿道中段耻骨后带(RT)和经闭孔带(TOT)是女性压力性尿失禁(SUI)最受欢迎的外科治疗方法。已经发表了一些比较不同技术的随机对照试验(RCT),结果相矛盾。目的:我们的目的是评估与其他外科手术治疗女性SUI相比,中尿道带的疗效,并发症和再手术率。证据收集:使用Medline,Embase,Scopus,Web of Science数据库和Cochrane系统评价数据库对文献进行了系统的回顾。证据综合:确定了39个RCT。接受尿道中段胶带的患者总体治愈率(优势比[OR]:0.61;置信区间[CI]:0.46-0.82; p = 0.00009)和客观治愈率(OR:0.38; CI:0.25-0.57; p <0.0001)尽管他们有较高的膀胱穿孔风险(OR:4.94; CI:2.09-11.68; p = 0.00003),但比接受Burch结肠直肠给药的患者高。接受尿道中段胶带和耻骨阴道吊带的患者治愈率相似,尽管后者储存尿道症状(LUTS)的可能性更高(OR:0.31; CI:0.10-0.94; p = 0.04),并且再手术率更高(OR:0.31; CI:0.12-0.82; p = 0.02)。接受RT治疗的患者的客观治愈率(OR:0.8; CI:0.65-0.99; p = 0.04)比接受TOT治疗的患者高;然而,主观治愈率相似,接受TOT治疗的患者发生膀胱和阴道穿孔的风险低得多(OR:2.5; CI:1.75-3.57; p <0.00001),血肿(OR:2.62; CI:1.35-5.08 ; p = 0.005),并存储LUTS(OR:1.35; CI:1.05-1.72; p = 0.02)。荟萃分析表明,TVT-O(利格大学,利格,瓦隆大区,比利时)和莫纳克公司(AMS,美国明尼苏达州明尼通卡)的结果相似。结论:接受RT治疗的患者的尿失禁率略高于采用Burch口服混悬液治疗的患者,但是他们面临更高的术中并发症风险。尽管使用耻骨吊带的患者更有可能发生贮藏性LUTS,但RT和耻骨吊带的效果相似。在使用RT之后,客观治愈率略高于TOT,但主观治愈率相似。与RT相比,TOT的膀胱和阴道穿孔以及储存LUTS的风险较低。这些结果的优势受到结局指标异质性和随访时间短的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号